Premium
Impaired response to interferon‐ γ in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide
Author(s) -
Llovera Marta,
Pearson Jeremy D,
Moreno Carlos,
RiverosMoreno Valentina
Publication year - 2001
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703838
Subject(s) - nitric oxide synthase , interferon gamma , lipopolysaccharide , tyrosine , tyrosine phosphorylation , nitrotyrosine , phosphorylation , nitric oxide , omega n methylarginine , chemistry , microbiology and biotechnology , biochemistry , biology , immunology , endocrinology , in vitro
Inducible NO synthase (iNOS) expression and activity were measured in the mouse macrophage cell line J774 after exposure to bacterial lipopolysaccharide (LPS) with or without interferon‐γ (IFN‐γ). Inhibition of NOS activity by concomitant N G ‐monomethyl‐ L ‐arginine ( L ‐NMMA) treatment further increased iNOS protein levels, with a substantial increase in iNOS half‐life. Western blotting and ELISA demonstrated that several cell proteins were tyrosine‐nitrated when iNOS activity was high. Rapid IFN‐γ‐induced phosphorylation of STAT1 was reduced by about 40% when cells were pretreated to induce iNOS, unless L ‐NMMA was present during the pretreatment period. 2D gel electrophoresis demonstrated the presence of nitrotyrosine in STAT1 after iNOS induction, and confirmed the reduction in phospho‐STAT1 on subsequent stimulation with IFN‐γ for 15 min and its partial restoration when L ‐NMMA was present during the pretreatment period. We did not detect tyrosine nitration of the upstream kinase JAK2 in LPS+IFN‐γ pretreated cells, but JAK2 activity was also impaired, and was partially restored by concomitant L ‐NMMA pretreatment. We conclude that endogenous production of NO induces feedback inhibition of signalling pathways activated by IFN‐γ, at least in part by nitrating tyrosine residues in STAT1 which prevents phosphorylation.British Journal of Pharmacology (2001) 132 , 419–426; doi: 10.1038/sj.bjp.0703838